After the initial enthusiasm subsided laser-coagulation of the prostate has
been criticized because the extent of tissue destruction cannot be control
led and many patients may be expected to have significant postoperative obs
tructive as well as irritative voiding symptoms which may last for weeks. T
hanks to new laservaporization techniques these disadvantages have been lar
gely eliminated. With the Holmium laser a real resection of prostatic tissu
e is possible allowing the surgeon to see the prostatectomy defect immediat
ely and to assess tissue destruction during the operation ("what you see is
what you get"). The postoperative voiding disturbances are diminished and
comparable to those after TUR-P.
At the Departement of Urology of the University of Berne 116 patients were
treated with the Holmium laser for benign prostatic hyperplasia (BPH). Duri
ng the initial learning period 12 patients required a secondary TURF due to
persistent obstruction and in 12 patients a combined laser/conventional re
section was performed due to underestimated prostate size. 5 patients were
lost to follow-up. In the remaining 87 patients the median duration of cath
eterization was 2 days. 10/87 patients required postoperative treatment for
urinary tract infection. There were no significant perioperative decreases
in hemoglobin and no cases of TUR syndrome.
66 patients have been followed for 6 months and 30 patients have been follo
wed for 12 months. The maximum urinary flow improved from 7 ml/s preoperati
vely to 15 ml/s at 6 months and 14 ml/s at 12 months. The volume of residua
l urine decreased from a median of 120 ml preoperatively to 24 ml at 6 and
12 months. The IPSS decreased from a median of 20 pre-operatively to 3 at 6
and 12 months. In 50 patients followed with pressure-flow study pre- and 6
months postoperatively detrusor pressure at maximum flow decreased from 90
cm H2O to 55 cm H2O and linear PURR sank from 2,06 to 0,6.
Taking into account the initial learning curve, transurethral Holmium laser
resection of the prostate is a promising method of treatment for BPH as sh
own by the increase flow and decrease in detrusor pressure. Although it doe
s not yet rank equally with TUR-P, it is a less invasive alternative provid
ing efficient, safe and almost bloodless treatment of BPH.